MaximusFRA:MMY +4.72%75 EBITDA Margin % is 13.88% as of Mar. 2026, which is 17% above its 10-year median of 11.89. GuruFocus rates FRA:MMY with a GF Score™ of 75/100 and a GF Value™ of €77.66 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,071 Business Services companies, Maximus ranks better than 58.73% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Maximus's EBITDA for the
three
months ended in Mar. 2026 was €157 Mil. Maximus's Revenue for the
three
months ended in Mar. 2026 was €1,130 Mil. Therefore, Maximus's EBITDA margin for the quarter that ended in Mar. 2026 was 13.88%.
Maximus (FRA:MMY) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Maximus EBITDA Margin % Related Terms
Maximus EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Maximus's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MMY vs FA, AZZ, CMPR: EBITDA Margin % Comparison
For the Specialty Business Services subindustry, Maximus's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maximus EBITDA Margin % vs Business Services Industry
For the Business Services industry and Industrials sector, Maximus's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Maximus's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maximus (FRA:MMY) has a EBITDA Margin % of 13.88% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Maximus and its competitors. This is 17% above median its historical median of 11.89. Over the past decade, Maximus' EBITDA Margin % has ranged from 9.05 to 15.68. According to the industry distribution chart, Maximus ranks #442 out of 1071 companies in the Business Services industry, placing it in the top 41.3%.
Is Maximus' EBITDA Margin % too high?
Maximus' current EBITDA Margin % of 13.88% is 17% above median its 10-year median of 11.89. Over the past 10 years, this metric has ranged from a low of 9.05 to a high of 15.68. The Business Services industry median EBITDA Margin % is 10.93. Maximus' value of 13.88% is 27% above this industry median. Based on the distribution chart, Maximus ranks #442 out of 1071 companies in the Business Services industry, which is above the industry midpoint. Overall, Maximus has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maximus' EBITDA Margin % compare to FA and AZZ?
According to the Business Services industry distribution chart, Maximus ranks #442 out of 1071 companies for EBITDA Margin %. This puts Maximus in the upper half of its industry. The industry median EBITDA Margin % is 10.93. Maximus' value of 13.88% is 27% above this benchmark. Historically, Maximus' own EBITDA Margin % has ranged from 9.05 to 15.68 over the past decade. While the company's 10-year median is 11.89 vs. the industry median of 10.93, Maximus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Business Services company?
The median EBITDA Margin % among Business Services companies is 10.93, based on 1,071 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maximus's current EBITDA Margin % of 13.88% is 27% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Maximus and its competitors. For the Business Services industry, the median EBITDA Margin % is 10.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maximus's current EBITDA Margin % is 13.88%, which is 17% above median its own 10-year median of 11.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maximus stock overvalued right now?
Based on GuruFocus' analysis, Maximus (FRA:MMY) is currently considered Significantly Undervalued. The stock's GF Value™ is €77.66, compared to a current price of €48.80 — trading 37.2% below its estimated fair value. The current EBITDA Margin % is 13.88%, which is 17% above median its 10-year median of 11.89 and 27% above the Business Services industry median of 10.93. Maximus' overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Maximus (FRA:MMY), the current EBITDA Margin % is 13.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maximus (FRA:MMY) Overvalued in 2026?
Based on GuruFocus' analysis, Maximus stock appears to be undervalued.
The current stock price of €48.80 is trading 37.2% below its estimated GF Value™ of €77.66.
GuruFocus considers Maximus to be Significantly Undervalued.
Key valuation signals for FRA:MMY:
EBITDA Margin %: 13.88% (17% above median its 10-year median of 11.89)
GF Value™: €77.66 vs. price of €48.80 (37.2% below fair value)
Industry Position: 27% above the Business Services median (#442 of 1071)
No single metric tells the full story. See the FRA:MMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
75GF Score
Get the complete analysis for FRA:MMY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MMY has been successfully added to your 
